Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Released Aug 9, 2018, after the close
10-Q filed Aug 9, 2018, 40 days after period end · 0001144204-18-043366
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $205.99K | $0.00 | — | — |
| Net Income | -$4.81M | -$1.89M | $5.97M | -$60.22M |
| EPS Diluted | -$0.41 | -$0.22 |
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
| $0.35 |
| -$1.80 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
